Health
India to review COVID-19 vaccines after blood clot warning – bdnews24.com
A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered…
India is currently administering AstraZenecas COVID-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called COVAXIN.
The review comes after Europes drug regulator said on Wednesday it found a possible link between AstraZenecas vaccine and rare blood clotting issues in adults who had received the shot, although it added the vaccines advantages still outweighed the risks.
India is banking on vaccinations to help contain a record…
Continue Reading
